Leki wg kodu ATC: A10BD19

• Glyxambi (Empagliflozinum + Linagliptinum)
  Boehringer Ingelheim International GmbH
• Glyxambi (Empagliflozinum + Linagliptinum)
  Boehringer Ingelheim International GmbH